4//SEC Filing
Nark Ted C 4
Accession 0001209191-21-030812
CIK 0001723128other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 2:08 PM ET
Size
9.4 KB
Accession
0001209191-21-030812
Insider Transaction Report
Form 4
Nark Ted C
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2021-05-06+46,218→ 108,784 total - Award
Restricted Stock Units
2021-05-05+35,406→ 35,406 total→ Class A Common Stock (35,406 underlying) - Exercise/Conversion
Restricted Stock Units
2021-05-06−46,218→ 0 total→ Class A Common Stock (46,218 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
- [F3]On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001316851
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 2:08 PM ET
- Size
- 9.4 KB